NR4A1 and breast cancer: Some articles studied the relationships between MYC amplification/overexpression and hormone receptors [17, 24] and found that MYC amplification/overexpression was more frequent in breast cancer without ER or PR expression, that could be used as a potential target in breast cancer of negative hormone receptors.